Abstract:Background: Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant disease with a low incidence rate. Indel mutations in the forkhead box L2 (FOXL2) gene cause two types of BPES that are distinguished by the presence (type I) or absence (type II) of premature ovarian failure (POF). The purpose of this study was to identify a possible deletion in FOXL2 in Chinese families with BPES and to clarify its relationship with POF.Methods: An autosomal dominant Chinese BPES family with four generations was enrolled in this study. Peripheral venous blood was collected from all affected patients, and genomic DNA was extracted from leukocytes. The whole coding sequence and nearby 5' untranslated region (UTR) and 3' UTR of the FOXL2 gene were amplified using polymerase chain reaction (PCR) with three sets of overlapping primers, followed by sequencing analyses. The sequencing results were analysed using SeqMan software. Based on the patients' clinical manifestations and analysis of the identified indel mutation, we found that the mutation disturbed interactions between FOXL2 and the StAR gene. Furthermore, through subcellular localisation and functional studies, we observed significant mislocalisation of the mutant protein; the mutant protein was found in the cytoplasm, while the wild-type protein was found in the nucleus. Loss of function was confirmed by transcriptional activity assays, quantitative real-time PCR, and electrophoretic mobility shift assays.Results: All affected patients presented with clinical features of BPES type I, including small palpebral fissures, ptosis, telecanthus, and epicanthus inversus with POF. A novel FOXL2 heterozygous indel mutation, c. 19_95del, a 77-bp deletion that disrupts FOXL2 protein structure, was identified in all affected members of the family. In addition, this indel mutation significantly increased StAR mRNA expression by disrupting the ability of the FOXL2 protein to bind to the StAR promoter and act as a repressor of this gene.Conclusions: A novel FOXL2 indel mutation was identified in Chinese families with BPES. Our results expand the spectrum of known FOXL2 mutations and provide additional insight into the structure-function relationships of the FOXL2 protein. Furthermore, this novel mutation resulted in the dysfunction of FOXL2 as a transcription factor, blocking its ability to bind to the promoter region of the StAR gene, resulting in POF in the affected patient.

The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.

Genetic and Functional Analyses of Two Missense Mutations in the Transcription Factor FOXL2 in Two Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.

[Analysis of FOXL2 Gene Mutations in 5 Families Affected with Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome].

Mutations of the Transcription Factor FOXL2 Gene in Chinese Patients with Blepharophimosis-Ptosis-epicanthus Inversus Syndrome.

Mutation Analysis of FOXL2 Gene in Chinese Patients with Blepharophimosis-Ptosis-epicanthus Inversus Syndrome

Functional study on a novel missense mutation of the transcription factor FOXL2 causes blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).

FOXL2 Mutations in Chinese Patients with Blepharophimosis-Ptosis-epicanthus Inversus Syndrome.

FOXL2 mutations in Chinese families with Blepharophimosis syndrome (BPES).

Functional Studies of Novel FOXL2 Variants in Chinese Families With Blepharophimosis–Ptosis–Epicanthus Inversus Syndrome

Novel FOXL2 Mutations Cause Blepharophimosis‐ptosis‐epicanthus Inversus Syndrome with Premature Ovarian Insufficiency

Seven Novel and Three Known Mutations in FOXL2 in 10 Chinese Families with Blepharophimosis Syndrome

Genetic Analysis of the Forkhead Transcriptional Factor 2 Gene in Three Chinese Families with Blepharophimosis Syndrome

A Novel FOXL2 Missense Mutation, C.1068g>c, in Chinese Families with Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type II

Identification of a Novel FOXL2 Mutation in a Single Family with Both Types of Blepharophimosis- Ptosis- Epicanthus Inversus Syndrome

A Novel FOXL2 Mutation in Two Infertile Patients with Blepharophimosis–ptosis–epicanthus Inversus Syndrome

Identification of a Novel FOXL2 Mutation in a Fourth-Generation Chinese Family with Blepharophimosis-Ptosis-epicanthus Inversus Syndrome.

A Novel FOXL2 Mutation Implying Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I

A Novel FOXL2 Mutation in a Chinese Family with Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome

Novel FOXL2 variants in two Chinese families with blepharophimosis, ptosis, and epicanthus inversus syndrome

Functional Analysis Of A Novel Foxl2 Indel Mutation In Chinese Families With Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Type I

The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome